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Cdk2 Knockout Mice Are Viable
G2/M transition. In general, regulation of the Cdk activityCyril Berthet,1,3 Eiman Aleem,1,3
Vincenzo Coppola,2 Lino Tessarollo,2 requires the interplay among the phosphorylation by
activating kinases (CAK, for review see [2]), their associ-and Philipp Kaldis1,*
1Regulation of Cell Growth Laboratory and ation with the cyclins, and the Cdk inhibitors (Cki). There
are two Cki families: the Ink4 family (p16Ink4a, p15Ink4b,2 Mouse Cancer Genetics Program
National Cancer Institute p18Ink4c, and p19Ink4d), whose members bind only to Cdk4
and Cdk6, and the Cip/Kip family (p21Cip1, p27Kip1, andBuilding 560
1050 Boyles St. p57Kip2), whose members bind all Cdks (for review see
[3]). In addition, all Cdk/cyclin/Cki complexes are af-Frederick, Maryland 21702-1201
fected by transcriptional regulation, subcellular localiza-
tion, and ubiquitin-mediated degradation, all of which
influence the progression through the cell cycle. Al-Summary
though we possess a wealth of knowledge about the
individual components of this regulatory network, in vivoBackground: Cyclin-dependent kinases (Cdks) and their
cyclin regulatory subunits control cell growth and divi- investigations of the cell cycle regulators remain neces-
sary if we are to fully understand their function andsion. Cdk2/cyclin E complexes are thought to be re-
quired because they phosphorylate the retinoblastoma identify potential overlapping pathways.
Cell cycle regulatory proteins were thought to be es-protein and drive cells through the G1/S transition into
the S phase of the cell cycle. In addition, Cdk2 associ- sential for mouse viability because of their crucial roles
in cell division. However, in vivo targeted disruption ofates with cyclin A, which itself is essential for cell prolif-
eration during early embryonic development. mouse genes encoding Cdk4 [4, 5], cyclin D1 or D2
[6–8], cyclin B2 [9], cyclin A1 [10], members of the Cip/Results: In order to study the functions of Cdk2 in vivo,
we generated Cdk2 knockout mice. Surprisingly, these Kip family [11–15], or members of the Ink4 family [16–19]
have not resulted in lethality. Developmental defectsmice are viable, and therefore Cdk2 is not an essential
gene in the mouse. However, Cdk2 is required for germ occur in some of the mouse models, indicating that
these regulatory proteins are important but not essentialcell development; both male and female Cdk2/ mice
are sterile. Immunoprecipitates of cyclin E1 complexes for viability. In contrast, cyclin A2 [20] and B1 [9] inactiva-
tion causes embryonic lethality; demonstrating thatfrom Cdk2/ spleen extracts displayed no activity to-
ward histone H1. Cyclin A2 complexes were active in these cyclins mediate essential functions in the develop-
ment of the mouse.primary mouse embryonic fibroblasts (MEFs), embryo
extracts and in spleen extracts from young animals. Using transformed cell lines and purified proteins, re-
searchers have been able to study Cdk2 extensively inIn contrast, there was little cyclin A2 kinase activity in
immortalized MEFs and spleen extracts from adult ani- the last decade. From these experiments, it was sug-
gested that Cdk2 orchestrates several cell cycle eventsmals. Cdk2/ MEFs proliferate but enter delayed into S
phase. Ectopic expression of Cdk2 in Cdk2/ MEFs (for review see [1]) such as G1/S transition, progression
in S phase through initiation and maintenance of DNArescued the delayed entry into S phase.
Conclusions: Although Cdk2 is not an essential gene replication, exit from S phase, progression into G2, and
maybe entry into mitosis [21]. The importance of Cdk2in the mouse, it is required for germ cell development
and meiosis. Loss of Cdk2 affects the timing of S phase, in the regulation of the cell cycle has been demonstrated
by the expression of a dominant-negative Cdk2 mutantsuggesting that Cdk2 is involved in regulating progres-
sion through the mitotic cell cycle. (D145N) that induces a G1 block in human osteosarcoma
cell lines [22]. This block is rescued by coexpression of
wild-type Cdk2 or cyclin D1. Furthermore, overexpres-Introduction
sion of the Cdk2 inhibitor p27Kip1 or microinjection of
antibodies against Cdk2, cyclin E, or cyclin A causesCyclin-dependent kinases (Cdks) are master regulators
cell cycle arrest [23, 24] and blocks initiation of DNAof eukaryotic cell proliferation (for review see [1]). Cdks
synthesis in mammalian cells [23, 25]. The most estab-are activated by binding to cyclin regulatory subunits.
lished function of Cdk2 is related to progression fromMore than ten different Cdks and cyclins have been
G1 to the S phase, which requires the sequential phos-identified. These are expressed in different combinations
phorylation of the retinoblastoma protein (Rb) by Cdk4/during specific phases of the cell cycle. The D-type cyclin-
Cdk6 and Cdk2 [26–29]. In its hypophosphorylated state,dependent kinases Cdk4 and Cdk6, whose expression
Rb sequesters the E2F family of transcription factorsis modulated by growth-stimulatory signals, function in
[28]. After phosphorylation of Rb by Cdk4/6 and Cdk2,early to middle G1 phase. They are followed by the
E2F proteins are released and promote transcriptionalactivation of Cdk2 in complex with cyclin E during late
activation of genes required for entry into S phase. InG1. Cdk2/cyclin A complexes function in S phase,
addition, Cdk2 mediates its functions through phos-whereas Cdc2/cyclin B and A complexes promote the
phorylation of many substrates, including targets that
trigger the firing of replication origins [30–35], regulate*Correspondence: kaldis@ncifcrf.gov
3These authors contributed equally to this work. centrosome duplication [36, 37], p53 [38], and the Cdk
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inhibitor p27Kip1 [39–41]. Phosphorylation of p27 on threo- After successfully targeting the Cdk2 locus, we aimed
to verify the absence of Cdk2 mRNA and protein innine 187 leads to the degradation of p27 and allows full
activation of Cdk2/cyclin E complexes. Although these Cdk2/ mice. We analyzed Cdk2 transcripts from thy-
mus by Northern blots. The insertion of the neomycindata suggest essential functions for Cdk2 in cell cycle
progression, it is unclear whether Cdk2 is essential in vivo. cassette prevented the expression of wild-type tran-
scripts in thymus of Cdk2/ animals (Figure 1C, leftRecently, it has been reported that human colon can-
cer cell lines proliferate normally after depletion of Cdk2 panel); nevertheless, we cannot exclude the possibility
that the neomycin cassette might affect the expression[42], indicating that Cdk2 is not required for cell cycle
progression in immortalized human cell lines. The clos- of neighboring genes of the Cdk2 locus. We also per-
formed RT-PCR on RNA from mouse embryonic fibro-est homolog of Cdk2 is Cdk3 [43]. Like Cdc2 and Cdk2,
Cdk3 can complement cdc28 temperature-sensitive blasts (MEFs). The full ORF of the Cdk2 cDNA was ampli-
fied from wild-type but not Cdk2/ MEFs (Figure 1C,mutations in budding yeast [43–46]. Expression of a
dominant-negative mutant of human Cdk3 blocks cells right panel). We observed the same result when we used
a reverse primer anchored in the deleted exon 4. Wein G1 phase [22], and Cdk3/cyclin E complexes can
promote S phase entry in quiescent cells as efficiently also investigated the expression of Cdc2 by Northern
blot and by RT-PCR. We found a similar level of expres-as can Cdk2/cyclin E complexes [47]. Nevertheless, a
non-sense mutation in the Cdk3 gene has been reported sion in tissues from animals of both genotypes, sug-
gesting that Cdc2 RNA expression was not affected byfrom most Mus musculus strains commonly used in the
laboratory [48], and this mutation prevents expression of inactivation of Cdk2. Western blot analysis corroborated
that the Cdk2 protein was not expressed in tissues ob-the Cdk3 protein in the mouse. Therefore, Cdk3 cannot
compensate for the loss of Cdk2 in the mouse. tained from Cdk2/ mice (see Figure 3A). Nevertheless,
a small Cdk2 transcript, encompassing exon 1 to exonWe generated Cdk2 knockout mice with a targeted
disruption of the kinase domain to determine Cdk2 func- 3, was detectable by RT-RCR in wild-type and knockout
animals (Figure 1C, right panel) although we were unabletions in the context of a living animal. Here we describe
the analysis of phenotypes of Cdk2 null mice and embry- to detect any truncated Cdk2 protein (data not shown).
Our data suggest that Cdk2/ mice do not expressonic fibroblasts (MEFs) derived from them. Cdk2/ mice
were unexpectedly viable and developed normally, but Cdk2 or its closest homolog, Cdk3, the two cyclin-
dependent kinases implicated in the control of the G1/Sthey were sterile and slightly smaller. Primary Cdk2/
MEFs were able to proliferate but displayed a delay in transition and S phase of the cell cycle.
entry into S phase. Cyclin E1 complexes did not display
kinase activity toward histone H1 in Cdk2/ spleen ex-
Phenotypic Analysis of Cdk2 Knockout Micetracts from adult animals. Cyclin A2 complexes were
To assess the role of Cdk2 in normal development, weactive in primary MEF, embryo, and spleen extracts from
intercrossed Cdk2/ mice. In the mixed strain back-young animals, but there was little activity in immortal-
ground (129S1/SvlmJ  C57BL/6), Cdk2-deficient miceized MEF or spleen extracts from adult animals. Our results
were born and viable (Figure 1D); however, the fre-suggest that Cdk2 is essential for meiosis and involved in
quency was slightly below the Mendelian ratio. From amaintaining normal proliferation in primary MEFs.
total of 234 animals, with a normal male:female ratio
(54:46), we observed 45 homozygote Cdk2/ miceResults
(19.2%) compared to 78 wild-type (33.3%) and 111 het-
erozygote (47.5%) siblings (2  9.92, p value  0.01).Generation of Mice Lacking Cdk2
Inactivation of Cdk2 may cause prenatal lethality at lowTo establish the in vivo role of Cdk2 in control of cell
penetrance, although at birth homozygous Cdk2 nullproliferation, we used gene-targeting techniques to gen-
animals did not differ in any obvious way from theirerate Cdk2-deficient mice. We functionally inactivated
littermates. In spite of the widespread expression ofthe Cdk2 gene in ES cells by homologous recombina-
Cdk2 during embryogenesis (data not shown), its losstion. In our targeting vector, we replaced exons 4 and
did not affect fetal development in the mixed back-5, encoding the core kinase domain of Cdk2, with a
ground 129S1/SvlmJ  C57BL/6. Survival of Cdk2/PGK-neomycin cassette to render Cdk2 nonfunctional
mice was not reduced; however, after weaning they were(Figure 1A). The complete Cdk2 locus (12.6 kb) was
slightly smaller than wild-type littermates (Figure 1D,retrieved from a bacterial artificial chromosome [49, 50].
left panel and data not shown). Nevertheless, Cdk2/This retrieval occurred by recombination between the
animals developed normally, and an anatomical and his-extremities of the Cdk2 locus and the retrieval vector,
tological examination of the mutant mice revealed nocontaining two short Cdk2 homology arms (70 base oli-
obvious malformations (data not shown), with the no-gonucleotides), in the context of E. coli deficient for the
ticeable exception of the gonads (Figure 1D, right panel).recBCD nuclease. Exons 4 and 5 were replaced by a
In fact, breedings of Cdk2/ males and females led toneomycin cassette according to the same strategy. After
vaginal plugs, suggesting a normal mating behavior, butelectroporation and double selection with G418 and
pregnancies did not occur. The same observations weregancyclovir, two independent embryonic stem (ES) cell
made for matings between wild-type and homozygotelines that had the Cdk2 locus correctly targeted were
mutant mice, indicating that both Cdk2/ males andidentified. We used these lines to generate chimeric
females are sterile. Indeed, a severe atrophy of the go-animals. Male chimeras were mated with wild-type
nads was observed even before sexual maturity andC57BL/6 females, and their offspring were analyzed for
became more severe in adult animals (ovaries are shownCdk2 recombination via PCR and Southern blotting (Fig-
ure 1B). in Figure 1D; see also Figure 2).
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Figure 1. Generation of Cdk2/ Mice and Cdk2 Expression Analysis
The Cdk2 gene was inactivated in ES cells via the targeting construct shown in (A). This strategy introduces a neomycin cassette in place of
exons 4 and 5. The PGK-TK was inserted at the 3 end of the targeting vector. 5 and 3 probes, located outside of the targeting vector, were
used for Southern blot analysis with a PstI digest. Southern blot analysis of recombined ES clones and offspring mice from a chimera is
shown in (B). Northern blots ([C], left panel) were performed on RNA from wild-type or Cdk2/ thymus with a Cdk2-5 probe (partial Cdk2
cDNA encoded by exon 1 to exon 3) and Cdc2 probe (full-length ORF). RT-PCR analyses ([C], right panel) were performed from RNA of MEFs
with Cdk2- or Cdc2-specific oligonucleotides (Cdk2 amplification: exon 1 to exon 3, exon 1 to exon 4, or full ORF; Cdc2 amplification: full-
length ORF). Cdk2/ mice are viable and develop normally, although adult animals appear to be slightly smaller than their littermates ([D],
left panel). Ovaries from wild-type and Cdk2/ animals are shown in (D) (right panel).
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Figure 2. Abnormal Germ Cell Development
in Cdk2/ Mice
Histological sections of gonads were stained
with hematoxylin and eosin. The males were
3 weeks old (A and B) or 3 months old (C–F),
and the females were 3 months old (G–J).
Tissues were fixed in 4% paraformaldehyde
for 24 hr prior to being processed and embed-
ded in paraffin wax. Wild-type seminiferous
tubules with normal germ cell differentiation
are shown in (A, C, and E). Cdk2/ seminifer-
ous tubules are smaller than the wild-type
and show defective germ cell development
(B, D, and F). Post-meiotic cells (late sperma-
tocytes, spermatids, and spermatozoa) are
absent. In vivo BrdU staining is shown in (C)
and (D). Wild-type ovaries with follicles are
shown in (G) and (I). Cdk2/ atrophic ovaries
display a lack of follicle development (H and
J). In vivo BrdU staining is shown in (I) and
(J). The scale bar represents 50 m for (A–F)
and (I–J) and 500 m for (G) and (H).
Defective Differentiation of Male germ cell development begins at the periphery of the
seminiferous tubule where spermatogonial stem cellsand Female Germ Cells
To determine the causes of the sterility in Cdk2/males, reside. These mitotic self-renewal cells differentiate pro-
gressively to spermatocytes, where meiosis occurs, andwe performed a histological analysis in sexually imma-
ture and mature male animals (Figures 2A–2F). Male to spermatids that colonize the more-internal tubular
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layers. Ultimately, spermatids yield mature spermatozoa thymus from wild-type and Cdk2/ extracts, whereas
cyclin A2 was detectable in liver and kidney and moder-that can be visualized in the lumina of the seminiferous
tubule ([51] and references therein). We observed that ately in lung from both types of extracts. Neither cyclin
E1 and nor cyclin A2 exhibited any difference in its ex-the seminiferous tubules underwent an overall size re-
duction resulting from a large depletion of germ cells pression pattern as a result of the loss of Cdk2 (Figure
3A). Similarly, p27, an inhibitor of Cdk2/cyclin E com-(Figures 2A/C/E versus 2B/D/F). Spermatozoa were
completely absent in the lumina, as in epididymis, con- plexes, was expressed at high levels in all tissues except
kidney in both genotypes. The p27 protein has to besistent with the sterility of these Cdk2/ animals. The
spermatogonia were present, and it seemed that Sertoli phosphorylated by Cdk2 on threonine 187 to be de-
graded, thus allowing full activity of Cdk2/cyclin E com-cells were not affected by the inactivation of Cdk2. In
accordance with these observations, the inactivation of plexes [39–41]. We used a phospho-specific antibody
(see Supplemental Experimental Procedures availableCdk2 induced a defect in the differentiation of male
germ cells in young animals. This phenotype was already with this article online) to detect the T187-phosphory-
lated form of p27 and observed an equivalent level ofobserved in three-week-old males (Figure 2A versus 2B),
showing that the first wave of germ line differentiation phosphorylation of p27 in wild-type and Cdk2/ tissues
(Figure 3A, bottom panel). This is in agreement with ourdid not take place and therefore that germ cells did not
enter meiosis in Cdk2 null males. The proliferation as findings that the levels of p27 were similar in both types
of tissues and indicated that other kinases can phos-measured by in vivo BrdU incorporation was similar in
wild-type and Cdk2/ testis (Figures 2C and 2D), corrob- phorylate p27T187.
Protein levels may not solely reflect the activity oforating that germ cells are affected after spermatogonia
proliferation when meiosis occurs. Cdk/cyclin complexes. Therefore, we performed immu-
noprecipitations from spleen extracts, a tissue showingUsing the same method, we analyzed ovaries to deter-
mine if oogenesis took place in Cdk2/ females. Female a high expression of Cdk2 (Figure 3A, lane 3), and ana-
lyzed the kinase activity (Figure 3B) and the bindinggerm cells proliferate through mitotic cell cycles before
they enter meiosis during embryonic development and partners of Cdk2 (Figure 3C). We analyzed the activity
of Cdks by using in vitro kinase assays and the substratearrest in prophase of meiosis I. These oocytes remain
arrested until puberty, when a pool of oocytes is re- histone H1. Immunoprecipitation of Cdk2 yielded high
Cdk2 activity from wild-type but not from Cdk2/ spleencruited to grow and complete the first meiotic division,
which is followed by a second meiotic round, when fertil- lysates (Figure 3B, lane 1 versus lane 2) from adult ani-
mals. Similarly, the kinase activity associated withization takes place [52]. We analyzed histological sec-
tions of ovaries from three-month-old Cdk2/ and wild- cyclins E1 and A2 was detectable in wild-type but not
in Cdk2/ spleen extracts from adult mice (Figure 3B,type females (Figures 2G–2J). In wild-type ovaries, we
observed a normal development of oocytes and different lane 3 versus lane 4, lane 5 versus lane 6, and lane 13
versus lane 14). The absence of cyclin E1 and A2 activitystages of follicles (Figures 2G and 2I). In Cdk2/ovaries,
we did not observe any primordial follicles, and appar- suggested that Cdk2 is the main kinase that binds
cyclins E1 and A2, at least in spleen tissue from adultently the oocytes did not develop in these atrophic ova-
ries (Figure 2H). BrdU staining was only detected in wild- mice. However, cyclin A2 activity was detected in
Cdk2/ embryo extracts (11.5 days post-coitum [dpc]),type (Figure 2I) and not in Cdk2/ ovaries (Figure 2J).
The absence of primordial follicle differentiation in Cdk2 spleen extracts from young animals (Figure 3B, lanes
10 and 12), and in primary Cdk2/ MEFs (see Figurenull animals suggests a block during embryonic devel-
opment prior to oocyte differentiation. An atrophy of the 4D). Therefore, cyclin A2 activity is present in embryonic
tissues, corroborating its being essential for embryonicuterus was also observed, possibly as a result of the
absence of ovary development, and may be linked to a development [20]. We observed a similar level of Cdc2
(Figure 3B, lanes 7 and 8) and cyclin B1 (data not shown)hormonal deficit (data not shown).
activity in both wild-type and Cdk2/ spleen extracts,
indicating that the Cdc2 activity was unchanged in the
Lack of Cyclin E1 Activity in Cdk2/ absence of Cdk2 activity. After immunoprecipitation
Spleen Extracts with Cdk2, cyclin E1, and cyclin A2 antibodies, as well as
In order to determine the impact of Cdk2 inactivation immunoblotting for Cdk2, we detected the Cdk2 protein
and to seek an explanation for the unexpected viability only in wild-type samples (Figure 3C and data not
of the Cdk2/ mice, we analyzed the expression of sev- shown). These results are in agreement with our obser-
eral cell cycle regulators in a range of adult tissues vations of the kinase activities. The Cdc2 protein was
(Figure 3). We performed Western blots by using anti- detectable after Cdc2 immunoprecipitation in wild-type
bodies against Cdks, cyclins, or Ckis. The Cdk2 protein and Cdk2/ spleen (Figure 3C), confirming that Cdc2
was expressed at high levels in thymus and spleen and protein levels and activity were similar in wild-type and
at low levels in kidney and lung but was not detectable Cdk2/ spleen extracts. Cdc2 was immunoprecipitated
in brain and liver (Figure 3A, top panel). In contrast, Cdk2 by cyclin A antibodies in wild-type spleen extracts from
was not expressed in all tissues from Cdk2/ mice young and adult animals. In Cdk2/ adult spleen extract,
(Figure 3A). The expression of Cdks (Cdk4, Cdk6, and the amount of Cdc2 bound to cyclin A was clearly re-
Cdc2) was similar in wild-type and Cdk2/ tissues, with duced (Figure 3C, right panel).
the exception of lower levels of Cdk6 in kidney from These results indicated that the in vivo expression of
Cdk2/ mice (Figure 3A, lanes 7 and 8). Cyclin E1 was all the cell cycle regulators tested was not affected by
the loss of Cdk2. Moreover, the absence of Cdk2 activityexpressed at high levels in brain and at lower levels in
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Figure 3. Expression of Cell Cycle Regula-
tors in Cdk2/ Tissues
Western blot analysis of Cdks, cyclin E1, and
cyclin A2 as well as p27 expression were per-
formed with 20 g protein lysates from vari-
ous adult tissues of wild-type or Cdk2/mice
(A). Cdk2/Cdc2-associated histone H1-kinase
activity was measured in wild-type or Cdk2/
spleen extracts from young and adult animals
or embryo extracts (11.5 dpc) after immuno-
precipitation with indicated antibodies and as
described in the Supplemental Experimental
Procedures (B). Immunoprecipitations of Cdk2,
cyclin E1, cyclin A2, cyclin A2sc (Santa Cruz
H-432), and Cdc2, as well as subsequent West-
ern blot analysis with antibodies against Cdk2
and Cdc2 are shown in (C).
did not affect p27T187 phosphorylation, which occurs in phase) one day earlier than for wild-type MEFs, indicat-
ing that contact inhibition in Cdk2/ MEFs than in wild-the G1/S phases, or the Cdc2 activation, which usually
happens in the G2/M phases of the cell cycle. Neverthe- type MEFs might occur at lower cell densities. This result
suggests that embryonic fibroblasts continue to prolifer-less, cyclin A2 activity was present in extracts from
embryos but not from adult spleen. Therefore, we aimed ate in the absence of Cdk2.
to investigate the transitions between the cell cycle
phases in more detail, and we addressed this question Cell Cycle Kinetics of Unsynchronized
Primary Fibroblastsin vitro by using mouse embryonic fibroblasts derived
from wild-type and Cdk2/ embryos. In order to gain insight into the mechanisms underlying
the proliferation in Cdk2/ fibroblasts, we studied the
cell cycle kinetics of primary unsynchronized MEFs 2Proliferation of Cdk2/ Mouse Embryonic Fibroblasts
We generated fibroblasts from Cdk2/ mouse embryos days after seeding (Figure 4B). We measured the propor-
tion of cells in S phase by pulse labeling cells with 100(13.5 dpc) and from wild-type littermate embryos to
study the proliferation of Cdk2/ MEFs. Cultures of pri- M BrdU 1 hr before harvesting the cells. In proliferating
populations of Cdk2/ MEFs, 28% of cells were in Smary Cdk2/MEFs were morphologically indistinguish-
able from those of wild-type MEFs. We plated 10,000 phase of the cell cycle, as indicated by BrdU incorpora-
tion, whereas in wild-type MEFs 25% were in S phasecells from both genotypes in 24-well plates and counted
them daily without passaging them. During the first 4 (Figure 4B). The percentage of cells in both G1 and G2/M
was also similar in both genotypes. Therefore, the samedays of culture, both Cdk2/ and wild-type MEFs dis-
played similar patterns of proliferation. From day 4 to number of cells were proliferating, corroborating that
primary MEFs lacking Cdk2 proliferate without major6, wild-type MEFs started to proliferate more quickly
than Cdk2/ MEFs (Figure 4A). The number of cells defect.
To further characterize the proliferation of wild-typeremained constant for Cdk2/ MEFs (entered plateau
Cdk2 Knockout Mice Are Viable
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Figure 4. Proliferation Analysis in Mouse Em-
bryonic Fibroblasts
Growth curves of wild-type and Cdk2/ MEFs
at early passage are shown in (A). Ten thousand
cells were seeded in each well and counted
every day. The number of cells at each time
point represents the average of triplicate wells.
The data shown represent the average of nine
Cdk2/ MEF clones from three different litters.
Cell cycle analysis of unsynchronized MEFs by
flow cytometry is shown in (B). Cells were pulse
labeled with BrdU for 1 hr at day 2 after being
seeded and were stained with propidium io-
dide. Data represent averages of two experi-
ments. Western blot analysis of the expression
of cell cycle proteins in unsynchronized MEFs
is shown in (C). Cdk-associated kinase activity
in unsynchronized MEFs is shown in (D). Cdk2-,
Cdk4-, or cyclin A-associated protein com-
plexes were immunoprecipitated from cell ly-
sates, and activity toward histone H1 or Rb was
measured in vitro as described in the Supple-
mental Experimental Procedures. MEF lysates
were immunoprecipitated (E) with antibodies
against Cdk2 (top panel), Cdk4 (second and
third panels from top), cyclin E1 (fourth panel
from top), cyclin A2 (first, second, and fourth
panels from bottom), and cyclin B1 (third panel
from bottom), and immunoblotted with anti-
bodies against Cdk2 (first, fourth, and fifth pan-
els from top), Cdc2 (bottom three panels), Cdk4
(second panel from top), or p27 (third panel
from top).
and Cdk2/ MEFs, we analyzed the expression of cell results from spleen extracts (see Figure 3B) and embryo
extracts (data not shown). Cyclin A2 activity was de-cycle regulatory proteins (Figure 4C) and their kinase
activities (Figure 4D). We used primary wild-type and tected in primary Cdk2/ MEFs (Figure 4D, second
panel from bottom) but not in immortalized Cdk2/Cdk2/MEF extracts to perform Western blots by using
specific antibodies against Cdks, cyclins, and p27 (Fig- MEFs (Figure 4D, bottom panel). The kinase activity of
Cdk4 toward Rb was similar in both Cdk2/ and wild-ure 4C). Protein levels of Cdc2, Cdk4, Cdk6, p27, cyclin
A2, cyclin E1, and cyclin B1 were similar in primary type MEFs (Figure 4D, second panel from top). These
results suggested that Cdk2/MEFs are able to prolifer-Cdk2/ MEFs and wild-type MEFs.
To measure the kinase activity of Cdks, we performed ate without increased Cdk4 activity.
In addition, we investigated the composition of theimmunoprecipitations, followed by kinase assays with
the substrates histone H1 or Rb (Figure 4D). Cdk2 activ- Cdk/cyclin/Cki complexes in lysates prepared from
wild-type and Cdk2/ MEFs to determine the impact ofity was detected in primary wild-type MEFs (Figure 4D,
top panel) but not in Cdk2/ MEFs, corroborating our the absence of Cdk2. We performed immunoprecipita-
Current Biology
1782
tions with lysates from both genotypes and antibodies lanes 1–7). The increase of Cdk2 activity coincided with
the entry into S phase (see Figures 5A and 5B). Cdk2against Cdk2, cyclin E1, cyclin A2, cyclin B1, and Cdk4,
then performed Western blots (Figure 4E). Cdk2 was activity was not detected in Cdk2/ MEFs (Figure 5C,
top panel, lanes 8–14). The cyclin A2 activity followedimmunoprecipitated with Cdk2 antibodies in wild-type
but not in Cdk2/ MEFs (Figure 4E, top panel). We the same pattern as Cdk2 in the wild-type MEFs (Figure
5C, middle panel, lanes 1–7), but there was little cyclinobtained the same result when we used immunoprecipi-
tates of cyclin E1 or A2 (Figure 4E, fourth and fifth panel A2 activity in the Cdk2/ MEFs (Figure 5C, middle panel,
lanes 8–14). However, after 34 hr (data not shown), cyclinfrom top). Cdc2 was bound to cyclin A2 in primary and
immortalized MEFs (Figure 4E, bottom two panels). Im- A2 kinase activity was increased to levels similar to
those shown in Figure 4D (second panel from bottom).munoprecipitation with antibodies against Cdk4 pulled
down similar amounts of Cdk4 protein from wild-type The cyclin B1/Cdc2-associated kinase activity followed
a pattern similar to that of the Cdk2 activity in wild-typeand Cdk2/ MEFs (Figure 4E, second panel from top).
In addition, we pulled down similar amounts of p27 in MEFs (Figure 5C, bottom panel, lanes 1–7). In Cdk2/
MEFs, the cyclin B1/Cdc2 activity was slightly lowerthe Cdk4 immunoprecipitates for each genotype (Figure
4E, third panel from top). This indicated that in the ab- than in wild-type MEFs (Figure 5C, bottom panel, lanes
8–14), which is most likely a result of the S phase delay.sence of Cdk2, the same amount of p27 is bound to
Cdk4. Finally, similar levels of Cdc2 were observed in In addition, as compared to wild-type MEFs, the Cdk2/
MEFs were spontaneously immortalized in a 3T3 proto-both wild-type and Cdk2/ MEFs after immunoprecipi-
tation with antibodies against cyclin B1 (Figure 4E, third col after a delay of approximately ten passages (data
not shown). Similar results have been recently reportedpanel from bottom).
Taking these results together, we found that wild-type for Cdk2/ MEFs [53] and for cyclin E1/cyclin E2/
MEFs [54].and Cdk2/ MEFs express similar levels of cell cycle
regulators. The loss of Cdk2 affected neither the amount From our in vitro studies on primary MEFs, we demon-
strated that the loss of Cdk2 has little effect on prolifera-of p27 bound to Cdk4 nor the formation of cyclin A2/
Cdc2 and cyclin B1/Cdc2 complexes. tion but that cells are delayed in their entry into S phase.
This phenotype was rescued by ectopic expression of
Cdk2 in the Cdk2/ MEFs. Further investigations will
Loss of Cdk2 Affects Timing of S Phase Entry help to link the in vitro phenotype to the in vivo defects
Unsynchronized cells do not reveal the timing of cell of germ cell development.
cycle progression; therefore, we synchronized our pri-
mary MEFs by serum starvation to study the impact of
loss of Cdk2 on the G1/S transition. MEFs were plated Discussion
at high densities (3–4  106 cells/100 mm-dish), starved
for 72 hr by culturing in medium supplemented with The goal of the present study was to determine the
functions of Cdk2 in vivo. We have generated mice lack-0.1% FBS, and then released by the addition of 10%
FBS. Cells were harvested at the indicated time points ing Cdk2 and found that they are viable. Loss of Cdk2
caused sterility and slightly decreased body weight inafter serum stimulation. In addition, cells from both
Cdk2/ and wild-type MEFs were pulse labeled with adult mice. Moreover, embryonic fibroblasts generated
from Cdk2/ embryos proliferated almost normally butBrdU for 1 hr and then subjected to flow cytometry
(Figures 5A and 5B). Wild-type MEFs started to enter S displayed a delay in S phase entry. The phenotype of
our Cdk2/ mice is very similar to the one describedphase by 12 hr, whereas Cdk2/ cells started to enter
into S phase between 14 and 15 hr (Figure 5B, left panel). when exons 2 and 3 are conditionally removed with the
Cre/loxP system [53].By 18 hr, a good percentage of wild-type MEFs were in S
phase, whereas Cdk2/MEFs required approximately 4 Mice lacking Cdk2 (in a Cdk3/ background) devel-
oped normally, indicating that Cdk2 is not required forhr more. These results suggest that the absence of Cdk2
delayed the G1/S transition by at least 4 hr or affected embryonic development in the mouse. Similarly, mice
lacking important cell cycle regulators (Cdks/cyclins/the total number of cells entering S phase. We confirmed
this observation by examining the BrdU incorporation Ckis) are viable (see Introduction and, for review, see
[55]). This indicates that other mechanisms can compen-during the 12–15 hr timeframe in 1 hr increments after
serum stimulation (data not shown). In order to investi- sate for the key cell cycle regulators, including both
Cdk2 and Cdk3. However, all of these knockout micegate if the S phase delay is due to the loss of Cdk2, we
reintroduced Cdk2-HA into Cdk2/ MEFs by retroviral exhibit various phenotypes in adult mice, demonstrating
that the ablated gene is required in specific tissues.infection (see Supplemental Experimental Procedures)
and synchronized the cells as described above. Expres- Cdk2 and Cdk4 share common features, such as that
they phosphorylate Rb and they bind to p27Kip1. We havesion of Cdk2-HA resulted in approximately twice the
number of cells entering S phase as did so in Cdk2/ shown in the present study that p27 is phosphorylated
on threonine 187, which is known to be a site for Cdk2,MEFs (Figure 5B, right panel), indicating that Cdk2 is
involved in regulating the timing of S phase entry. in wild-type and Cdk2/ tissues (Figure 3A). Therefore,
kinases other than Cdk2 are able to phosphorylate p27We performed kinase assays by using histone H1 as
a substrate, after immunoprecipitation with antibodies on threonine 187. The most likely candidate is Cdc2
because it displays substrate specificity similar to thatagainst Cdk2, cyclin A2, or cyclin B1. Cdk2 kinase activ-
ity toward histone H1 was detected after 18 hr and in- of Cdk2 in vitro, although other kinases cannot be ex-
cluded at this time. This phosphorylation leads to thecreased up to the 24 hr time point (Figure 5C, top panel,
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Figure 5. Delayed Entry into the S Phase of
Cdk2/ MEFs after Serum Starvation
MEFs were harvested from wild-type and
Cdk2/ embryos at 13.5 dpc and cultured in
the presence of 10% FBS for two passages.
We then induced quiescence by culturing cells
in 0.1% FBS for 72 hr (time zero) and subse-
quently stimulated cells with medium con-
taining 10% serum. Cells were pulse labeled
with 100 M BrdU for 1 hr and harvested at
the times indicated after stimulation. Cells were
stained with anti-BrdU antibodies and propid-
ium iodide and subjected to flow cytometry (A).
The X axis represents the DNA content, and
the Y axis represents the amount of BrdU incor-
porated into newly synthesized DNA. The up-
per left panel shows the gate settings for cells
in G1, S, and G2/M phases of the cell cycle.
The percentage of cells in S phase from each
time point was calculated and plotted (B) from
data shown in (A). Cdk2/ MEFs display a de-
lay in S phase entry at 12 hr after stimulation
([B], left panel). Cdk2-HA was reintroduced by
retroviral transfer into Cdk2/ MEFs, and the
experiment shown in (A) was repeated ([B], right
panel). Cdk2-, cyclin A2-, and cyclin B1-associ-
ated kinase activity is shown in (C). Cdk2, cyclin
A2, and cyclin B1 complexes were immunopre-
cipitated from 200 g cell lysates, and kinase
activity toward histone H1 was measured in
vitro as described in the Supplemental Experi-
mental Procedures.
degradation of p27 [39–41]. In agreement with this result, no stringent requirement for Rb to be phosphorylated
by Cdk2. On the other hand, the expression of dominant-we did not observe elevated levels of p27 in Cdk2/
tissues or MEFs (Figures 3A and 4C). negative mutants of Cdk2 and Cdk3 caused a G1 block
in human U2OS osteosarcoma cells and other cell linesThe delay in S phase entry in Cdk2/ MEFs is similar
to that observed in Cdk4 null MEFs [5] and suggests [22] and inhibited mitogen-induced cell proliferation of
oligodendrocyte progenitors [56]. These observationsthat Cdk2 activity is required for proper timing of S phase
entry. One function of Cdk4 is to sequester p27, and it are in agreement with the notion that Cdk2 is dispens-
able for cell proliferation but might be required in spe-thus prevents inhibition of Cdk2 activity by p27. In
Cdk4/ MEFs, more p27 is bound to Cdk2, thus lowering cific cell lines or tissues, as we reported for germ line
development. In addition, the Cdk2D145N phenotype isits activity [5]. The delay in S phase entry in Cdk4/
MEFs is most likely due to Cdk2 inhibition because the rescued by cyclin D1 and, with less efficiency, by both
cyclins A and E [22]. Therefore, the mechanisms bydelay was almost completely rescued by removal of p27
in Cdk4/p27/ MEFs [5]. Therefore, Cdk2 is one of the which Cdk2D145N arrests cell lines might include more
than suppressing the endogenous Cdk2 kinase activity.determining factors for timing of S phase entry, which
is consistent with our results (see Figure 5). One of the main reasons that Cdk2/ mice are viable
could be related to the cyclin A2 activity. Cyclin A2 bindsBoth Cdk4/6 and Cdk2 phosphorylate Rb, which acti-
vates the transcriptional activity of E2F by releasing it to Cdk2, and Cdc2 and is an essential gene in the mouse
[20]. In the absence of Cdk2, cyclin A2 is still able tofrom sequestration [26, 28, 29]. One possible explana-
tion for the progression of the cell cycle in the absence bind to Cdc2 and therefore fulfill its essential missions.
In primary Cdk2/ MEFs, cyclin A2 is active (see Figureof either Cdk2 or Cdk4 would be that one could compen-
sate for the other if it were lost. It has been shown that 4D and [53]), but upon ablation of Cdk2 in the immortal-
ized human C33A cell line, there is no detectable cyclinCdk4 was able to phosphorylate Rb on Cdk2-specific
sites in certain colon cancer cells when depleted of A activity [42]. Our results indicate that although there
is cyclin A2 activity in primary MEFs, there is very littleCdk2 [42]. Inhibition of Cdk2 activity by overexpression
of p27, expression of a dominant-negative mutant of in immortalized MEFs (Figure 4D). Furthermore, we de-
tected cyclin A2 activity in embryo and spleen extractsCdk2 (D145N), or depletion of Cdk2 through antisense
oligonucleotides did not cause cell cycle arrest in spe- from young animals, but there was no cyclin A2 activity
in spleen extracts from adult animals. These results sug-cific colon cancer cell lines [42], indicating that there is
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cycle is not impaired in the absence of Cdk2 could be
related to cyclin E. Binding of cyclin E to Cdk2 in late
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